The present disclosure relates generally to orthopedics and in particular to deep vein thrombosis (“DVT”) and thermal/compression therapy systems, apparatuses and methods.
DVT is a condition that occurs when a blood clot forms in a patient's vein deep in the body, usually in the patient's legs or the feet. The clot can block proper blood flow and may lead to severe injury or death if the clot breaks off and travels through the bloodstream to other areas of the body, such as the brain or lungs. Doctors sometimes recommend compression therapy for people with or prone to developing DVT.
Compression therapy works by exerting varying degrees of pressure on the legs, especially the lower legs, which helps the blood to flow back towards the patient's heart. The pressure helps blood in the surface level veins travel to the deeper veins and back to the heart rather than collecting and clotting in the lower extremities. Compression therapy also helps to reduce pain and swelling associated with DVT.
One way to exert pressure on the patient's legs is via compression stockings. For a minimal amount of pressure, women's type pantyhose may be sufficient. If moderate support is required, over-the-counter compression stockings from a pharmacy or medical supply store may be used. There are also prescription strength compression stockings, which need to be fitted to the patient.
The patient should wear the compression stockings every day, as long as the patient is experiencing DVT-related symptoms or is at risk for developing DVT. The stockings should be worn throughout the day, even while exercising. The patient can remove the stockings for bathing and at night when while sleeping.
Patients who suffer from advanced arterial disease or poorly controlled congestive heart failure should not wear compression garments. Compression garments may worsen the disease in diabetics, smokers and those who have poor circulation in the legs if compression garments are worn. The compression garments can also cause skin infection.
If compression garments cannot be worn, or if additional DVT therapy is needed, pneumatic compression may be applied. For example, hospital patients that are bedridden or have recently undergone surgery are often treated with pneumatic compression devices to help prevent DVT. Known pneumatic compression devices include sleeves or cuffs that are applied around a patient's lower extremity and fastened removably by hook and pile straps for example. The cuffs are connected to a pump enabling the cuff to be inflated and deflated to aid in blood flow from the lower extremity back to the patient's heart.
As discussed, compression garments can be uncomfortable. This can be especially true in warmer climates. Compression garments are also not available to every DVT patient. And pneumatic compression devices have for the most part been used in hospitals. A need accordingly exists for a relatively low cost pneumatic compression device that can be used in the patient's home, in addition to or in the place of compression garments.
The present disclosure provides a combination pressure therapy system, method and apparatus, for example, to treat deep vein thrombosis (“DVT”) and other diseases, ailments and pain, such as sore muscles or joints. The system in one embodiment is microprocessor-based and includes electronics having at least one processor, memory device, power supply (e.g., to convert alternating current (“AC”) voltage to direct current (“DC”) voltage), and input/output switching. Input/output switching receives commands from the processor, according to a computer program stored on the memory device. The processor receives signals (e.g., via the input/output switching) from various sensors, such as pressure sensors. The processor in response to the signals (or to an input from the user) commands the input/output switching to control a pump and valves to nm a selected therapy.
The system includes a user interface, which includes on/off input devices or switches that allow the user to turn on and off one or more therapy of the system. The user interface may also have one or more display or readout, such as a temperature display for a thermal/compression therapy and/or a pressure readout for a DVT therapy. The system in one embodiment provides both a DVT therapy and a thermal/compression therapy. The user interface may include a master on/off switch that turns the system on and off and a second switch that controls just the thermal/compression therapy. Thus only the master switch needs to be turned on to run the DVT therapy in one embodiment. Both switches need to be turned on to runm only the thermal/compression therapy or to run both therapies.
The DVT therapy can include two pneumatic lines, each leading to a DVT cuff (e.g., left and right) in one embodiment. The pneumatic lines in an embodiment each operate with a control valve and a bleed valve. The valves can each be normally closed valves, such that the control valves are each opened to pressurize the lines (and cuffs) upon energization, while the bleed valves are each opened to depressurize the lines (and cuffs) upon energization. The pneumatic lines each include a pressure sensor or transducer, which sends a pressure signal back to the control electronics. The pressure signal is used as feedback to maintain the pressure in the lines at a preset, desired pressure. The bleed valves in one embodiment are adjustable to maintain a residual pressure in the pneumatic lines upon depressurization. Alternatively, the valves are depressurized to atmospheric pressure.
The DVT cuffs can be pressurized in many different ways in which the duration of the pressurization, the rate at which the maximum pressure is reached and the maximum pressure itself can be varied. In the illustrated embodiment below, the left and right cuffs are pressurized at different times so that the pump does not have to be sized to inflate both cuffs simultaneously. The cuffs could alternatively be pressurized at the same time or have overlapping pressurizations. In one embodiment illustrated below, the first cuff is inflated for six seconds from time zero and then deflated to a residual pressure. The second cuff is then inflated for six seconds beginning from time six seconds from zero to time twelve seconds from zero and then deflated to a residual pressure. After twelve seconds, both cuffs remain at the residual pressure until time sixty seconds from zero at which time the sequence just described is repeated. While the below example shows two cuffs, the system could alternatively provide and inflate one cuff or more than two cuffs, e.g., in a non-overlapping manner.
The system in one embodiment also provides a thermal/compression therapy wrap, which includes an inner chamber that receives a flow of water, e.g., chilled water, pumped from an ice bath, and an outer chamber that receives pressurized air. In one embodiment, the pressurization of the thermal/compression therapy wrap is controlled by the same processor that controls DVT cuff inflation, but is completely independent of DVT inflation and vice versa. Like with the DVT cuffs, the compression wrap can be pressurized in many different ways in which the duration of the pressurization, the rate at which the maximum pressure is reached, and the maximum pressure itself can be varied. In one embodiment illustrated below, pressure in the wrap is ramped up slowly, e.g. over forty-five seconds, in a linear manner, and then ramped down slowly, e.g. over forty-five seconds, in a linear manner. Pressure feedback is used with the electronics to control the desired waveform.
The thermal/compression pressure waveform can be run (i) by itself, (ii) while the DYT pressure waveforms are being run and in sync with or as part of an overall sequence or cycle with the DVT waveforms, or (iii) while the DVT pressure waveforms are being run and out of sync with or completely independent of the DVT waveforms. In either (ii) or (iii), the wrap can be inflated at the same time or at different times than the DVT cuffs are inflated. The thermal/compression therapy wrap can therefore be worn by itself or in combination with the DVT cuffs. While the DVT cuffs are generally worn at the lower portions of the user's legs, the thermal/compression therapy wrap can be worn anywhere thermal/compression therapy is needed. For example, if a patient has had knee surgery, the thermal/compression therapy wrap can be worn around the healing knee to reduce swelling, while the DVT cuffs are worn close to the patient's ankles to help keep blood circulating within the patient over prolonged periods of rest and non-movement. This application can be performed immediately after surgery at the hospital and/or later when the patient returns home.
As discussed in detail below, in one embodiment, the pump pressurizes a reservoir that is used in turn to pressurize the DVT cuffs and the thermal/compression therapy wrap. Alternatively, one or more pump(s) are used to directly pressurize the DVT cuffs and the thermal/compression therapy wrap. In either case, pressurized air is used in each pneumatic line with a control valve, bleed valve and pressure sensor in one embodiment to achieve the pressure profile stored in and executed by the electronics.
In one embodiment, each DVT cuff is attached to a single pneumatic line, which is advantageous for cost, weight and simplicity reasons. Each cuff includes two inflatable chambers that are fluidly separated from each other. Each DVT pneumatic line extends from the housing of the system and splits at the DVT cuff into a first line segment and a second line segment. The first line segment extends to a distal air chamber (distal on leg relative to the heart when the cuff is properly donned), which is pressurized first when the pneumatic line is pressurized. The second line segment extends to a proximal air chamber (proximal on leg relative to the heart when the cuff is properly donned), which is pressurized second when the pneumatic line is pressurized.
The delay in pressurizing the second or proximal air chamber is caused by a flow restricting structure that is placed in the second line segment or in a passageway in the cuff leading from the second line segment to the second air chamber. For example, the first and second line segments can split at a “Y” connector. The “Y” connector can be outside the cuff, inside the cuff or pathway outside and pathway inside the cuff. The flow restricting structure can be a narrowed and/or torturous passageway formed or placed in a second line segment portion of the “Y” connector. Or, the flow restricting structure can be a pneumatically operated valve check valve formed or placed in a second line segment portion of the “Y” connector. Here, pressure has to build to a certain point before the check valve opens, delaying pressurization of the proximal chamber. A return check valve can be provided in addition, allowing the proximal chamber to deflate when desired. The flow restricting structure is further alternatively a torturous and/or narrowed passageway in the cuff leading to the proximal chamber. The cuff can be sealed together from two plastic sheets to form the chambers. The same process can form baffles that extend part way across the cuff passageway and alternate, forcing air to move in a serpentine manner through a narrowed cross-section. Still further alternatively, the flow restricting structure can be any combination of the structures just described.
It is accordingly an advantage of the present disclosure to provide a pneumatic pressure therapy system that is relatively low cost.
It is another advantage of the present disclosure to provide a pneumatic pressure therapy system that is relatively easy to use.
It is a further advantage of the present disclosure to provide a pneumatic pressure therapy system that includes both DVT and thermal/compression therapy.
It is yet another advantage of the present disclosure to provide a pneumatic pressure therapy system that flexibly allows for different pressure profiles, which may be provided as selections for the user.
Additional features and advantages are described herein, and will be apparent from the following Detailed Description and the figures.
Referring now to the drawings and in particular to
For ease of illustration, alternative (ii) has been chosen for illustration and description, as illustrated by system 10 in
System 10 includes an air pump 12, for example, an Oken Sieko air pump, part number P54E01R. Pump 12 is powered via electronics 50, which can output alternating current (“AC”, e.g., 110/120 or 230/240 VAC) or direct current (“DC”, e.g., 24 VDC) to pump 12 and/or to the valves as described below. Electronics 50 can include one or more processor 52 and memory 54. Electronics 50 may also include a power supply 56, e.g., for converting AC line voltage 60 to DC voltage for powering pump 12 and the associated valves and/or pressure sensors. Electronics 50 also include input/output switching 58 that receives commands from processor 52 and switches electrical contacts to either allow or disallow power to be delivered to the pumps, valves and pressure sensors.
Pump 12 pumps to an air reservoir 20 in the illustrated embodiment, which can be a plastic or metal container sized and arranged to hold the maximum pressure that can be supplied via pneumatic line 22d by pump 12, plus an engineering factor of safety, e.g., 1.5 to 2.0 times the maximum pump output. Air reservoir 20 holds pressurized air supplied to pneumatic lines 22a, 22b and 22c, which in turn feeds pressurized air to left DVT cuff 100a, right DVT cuff 100b and thermal/compression therapy wrap 200, respectively. Pneumatic lines 22a, 22b and 22c are controllably pressurized by control valves 14, 16 and 18, respectively, which (i) open to allow the pneumatic lines 22a, 22b or 22c to become pressurized and (ii) close to prevent further pressurization of the line. When pneumatic lines 22a, 22b, 22c are pressurized, left cuff 100a, right cuff 100b and thermal/compression wrap 200 are likewise respectively pressurized (e.g., according to staggered pressure chamber structures discussed below).
Pneumatic lines 22a, 22b and 22c are each fluidly connected to a respective bleed valve 24, 26 and 28. Control valves and bleed valves may be, for example, valves provided by Koganei, part number GA010HE1. Bleed valves 24, 26 and 28 enable pneumatic lines 22a, 22b and 22c and respective cuffs 100a, 100b and 200 to be depressurized. Depressurization of the lines and cuffs can be to atmospheric pressure. Alternatively, depressurization is to a modulated residual pressure, e.g., at slightly above zero gauge pressure. Thus with control valves 14, 16 and 18 closed, if bleed valves 24, 26 and 28 are opened, pressure in the respective lines and cuff, or wrap, is bled to zero gauge pressure or a slightly higher residual pressure.
Pneumatic lines 22e, 22f and 22g extend off of pneumatic lines 22a, 22b and 22c, respectively, and feed respective pressure sensors 34, 36 and 38. Pressure sensors 34, 36 and 38 send pressure signals back to electronics 50, enabling (i) feedback to electronics 50 so that respective cuffs 100a, 100b and wrap 200 can be initially inflated to a desired pressure, and (ii) feedback to electronics 50 so that pressure in the cuffs and wrap can be maintained by opening control valves 14, 16 or 18 to add pressure if needed or opening bleed valves 24, 26 and 28 to relieve pressure if needed. Processing 52 and memory 54 are programmed to receive the pressure signals, decide what action if any is needed, and operate input/output switches 56 to control the appropriate valve. As discussed in more detail below, electronics 50 and pump 12 operate to replenish reservoir 20 as needed so that the pressurization of cuffs 100a and 100b and wrap 200 can be performed repeatedly, as long as it is desired.
In
As shown in
Bleed valves 24, 26 and 28 enable left cuff 100a, right cuff 100b and compression wrap 200 lines 22a, 22b and 22c to vent to atmosphere, that is, relieve pressure in the lines. Bleed valves 24, 26 and 28 can be adjustably modulated to leave a residual pressure in their respective lines 22a, 22b and 22c. It is contemplated in one embodiment to set bleed valves 24, 26, and 28 to leave about 10% of the maximum pressure (e.g., from 1.0 psig down to 0.1 psig) when the lines are depressurized. Valves 14, 16, 24 and 26 control the DVT therapy, while valves 18 and 28 control the thermal/compression therapy.
In the illustrated embodiment, a single air pump 12 supplies a reservoir, which will have a maximum pressure output for example of about eight psig. Reservoir 20 will supply each of left cuff 100a, right cuff 100b and compression wrap 200 to achieve the desired pressure waveform rise times discussed below. Reservoir 20 also dampens the pulsatility of the output of air pump 12 and thereby smoothes the pressure changes in the below—discussed pressure waveforms. Further, reservoir 20 lessens the frequency that air pump 50 has to be started and stopped, thereby extending the life of the air pump 12.
Air pump 12 fills reservoir 20 as required, periodically over any of the pressure cycles discussed herein. Reservoir 20 can have a pressure sensor (not illustrated) that feeds back a pressure signal to the electronics 50, which uses the signal to control pump 12 to maintain pressure within the reservoir. Alternatively, the electronics 50 may operate with a high pressure switch (not illustrated) to detect a maximum preset pressure for reservoir 20 and shut the air pump 12 off for a preset period or until a second, low pressure switch signals to turn pump 12 back on to regulate pressure in the reservoir 20. Further alternatively, software employed by processing 52 and memory 54 of electronics 50 may anticipate the pressure of the reservoir 20 via knowledge of the operational pressure cycle and shut the air pump 50 off in an open loop fashion to control the pressure of reservoir 20. In any of these scenarios, air pump 12 maintains the reservoir 20 in one embodiment at about two to about eight psig. The relatively low reservoir pressure allows left cuff 100a, right cuff 100b and compression wrap 200 lines 22a, 22b and 22c to operate respectively without relief valve(s). However, a relief valve that opens if the pressure in a respective one or more lines 22a, 22b and 22c increases too much could be added if desired to any one or all of those lines. In such a case, a higher pressure in reservoir 20 can be maintained.
Left cuff 100a and right cuff 100b are two separate cuffs (e.g., one for the patient's left leg and one for the patient's right leg), each having, e.g., two chambers, a distal chamber (pressurized first) and a proximal chamber (pressurized shortly afterward). Thus in the illustrated embodiment, each of the left and right cuffs 100a and 100b is a single line cuff and is operated as discussed next.
In one DVT waveform embodiment, air pump 12 is energized at time T-0. With bleed valve 26 closed (de-energized), control valve 14 is opened (energized) immediately after time T-0, at time T-1, and stays open until pressure sensor 34 reads about 0.8 psig, at which time control valve 14 is closed (de-energized). Control valve 14 is then toggled on and off, using pressure feedback from pressure sensor 34, so that the 0.8 psig pressure is maintained in the left cuff line 22a and the left cuff 100a for a specified duration, e.g., six seconds, the end of which corresponds to a time T-2. Control valve 14 is then closed (de-energized) for the remainder of the cycle, while bleed valve 24 is opened (energized) for the remainder of the cycle time, e.g., until sixty seconds after time T-0, to relieve pressure in the left cuff line 100a to a non-zero pressure (e.g., 0.1 psig) set by modulating bleed valve 24. Thus in one implementation, the opening of bleed valve 24 relieves pressure in the left cuff line 22a and left cuff 100a to about 0.1 psig during the remainder of time from T-2 until sixty seconds after time T-0. A relief valve (not illustrated), if provided in left cuff line 22a, would be set at some pressure above one psig.
Continuing with the DVT therapy, while bleed valve 26 is closed (de-energized), control valve 16 is opened (energized) at time T-2, allowing right cuff line 22b and the right cuff 100b to become pressurized at the time when the left cuff line 22a and the left cuff 100a are vented to their residual pressure as just described. Control valve 16 is then toggled on and off, using pressure feedback from pressure sensor 36, so that about 0.8 psig pressure is maintained in the right cuff line 22b and the right cuff 100b for a specified period, e.g., six seconds, the end of which corresponds to time T-3. Control Valve 16 is then closed (de-energized), while bleed valve 26 is opened (energized) for the remainder of the time until time T-2 occurs in the next cycle, the next cycle beginning sixty seconds after time T-0. The opening of bleed valve 26 relieves pressure in the right cuff line 22b and the right cuff 100b, again to about 0.1 psig, during the remainder of time until control valve 26 is next opened (energized) and bleed valve 26 is closed (de-energized). A relief valve (not illustrated), if provided in right cuff line 22b, would again be set at some pressure above one psig.
The DVT sequence just described is illustrated graphically in
Each DVT cuff 100a and 100b includes at least two chambers (dotted line in
For the thermal/compression therapy, with bleed valve 18 closed (de-energized), control valve 28 is opened (energized), allowing the pressure in the compression cuff line 22e and the compression cuff 200 to build in a linear fashion to about 0.8 psig over forty-five seconds. At the forty-five second mark, control valve 18 is closed (de-energized) and bleed valve 28 is opened (energized) to atmosphere to allow the pressure in the compression cuff line 22c and the compression cuff 200 to ramp down in a linear fashion over the next forty-five seconds to a fraction of the 0.8 psig maximum, e.g., to about 0.1 psig. The ninety second sequence is then repeated as illustrated in
In one embodiment, the control by electronics 50 of the DVT and thermal/compression therapies is completely separated. Either therapy can operate while the other therapy is performed or not performed. Both therapies can be run simultaneously, but if so, the sixty second cycle of the DVT therapy is completely independent in one embodiment, of the ninety second cycle of the thermal/compression therapy. The DVT Therapy can be started at the same time as, or at any time after, the thermal/compression therapy is started and vice versa.
The ramping up of pressure in DVT left cuff 100a is achieved using pressure feedback from pressure sensor 34, control valve 14 and the electronics 50. The ramping up of pressure in the DVT right cuff 100b is achieved using pressure feedback from pressure sensor 36, control valve 26 and the electronics 50. The linear ramping up of pressure in the thermal/compression therapy wrap 200 is achieved using pressure feedback from pressure sensor 38, control valve 18 and electronics 50 to modulate a pressure profile to build to 0.8 psig linearly over forty-five seconds. Likewise, the linear ramping down of pressure in thermal therapy/compression wrap 200 is achieved using pressure feedback from the same pressure sensor 38, bleed valve 28 and electronics 50 to modulate a pressure profile via the bleed valve to relieve from 0.8 psig down to close to atmosphere over the following forty-five seconds. The valve states for the DVT and thermal/compression therapies are shown respectively in
Referring now to
The overall cycle consumes about seventy-five seconds. At the end of seventy-five seconds, the cycle of
Any of the waveforms in
While not illustrated in
The housing in
Valves 14 to 28 are all electrically operated solenoid valves in the illustrated embodiment, which electronics 50 operates to open and close as discussed above. If relief valves are provided, they can be pressure operated valves that open upon a mechanically adjusted bursting pressure and therefore do not require electronic control. As discussed, the electronics 50 receives signal feedback from pressure sensors 34, 36 and 38, which are used as feedback to control valves 14, 16 and 18, respectively. Pressure sensor 38 is also used as feedback to control bleed valve 28 for the linear deflection of thermal/compression wrap 200.
Referring now to
With any of the three options, cuff 100 is made using two flat sheets of material, such as thermoplastic polyurethane (“TPU”) or vinyl sheets, that are heat sealed, sonically sealed, and or solvent bonded, along their outer peripheries 112 to form a unit and along inner seal lines 114 to form the two proximal and distal air chambers 110 and 120 and attachment flaps 102 and 104. Flaps 102 and 104 have mating hook or pile closures 106 and 108, respectively. For each of the three options, a single line or tube 22 (any of tubes 22a, 22b or 22c) leads to the cuff assembly for air to enter the distal 110 and then the proximal 120 chambers of the cuff 100. Air also leaves the cuffs via the single line. A “Y” connector 130 splits the single line air pathway 22 near cuff 100 into two small tubing or line segments 122 and 124, including a proximal tubing segment 124 that attaches to and seals to the proximal air chamber 120 and a distal tubing segment 122 that attaches to and seals to the distal air chamber 110.
The three alternatives of
In
In
In
Line 22 maintains pressure over the DVT inflation period, e.g., the six seconds out of a minute as described in connection with
Because first check valve 132 assures that there is a pressure differential during inflation, the resulting cuff 100 has a “gradient pressure”, in which the distal air chamber 110 is inflated to a higher pressure than the proximal chamber 120. This type of pressure gradient has been shown to be therapeutically beneficial. Appropriately engineered duckbill valves are well-suited because of their low cost and simplicity, but other types of check valves could be used alternatively. As shown in
If desired, any of the flow restricting structures described in
Referring now to
In
Referring now to
In
As illustrated, one outlet branch 122 of “Y” tubing connector 130 extends into distal chamber 110, while the other outlet branch 124 of “Y” tubing connector 130 extends into the tortuous pathway 116 leading to proximal chamber 120. In this manner, distal and proximal chambers 110 and 120 remain pneumatically separated from each other. Sequential inflation of chambers 110 and 210 occurs as described above.
Referring now to
In
Regarding the thermal/compression therapy wrap 200, alternative structures contemplated include: (i) three layers of, for example, thermoplastic polyurethane (“TPU”) or vinyl, material of the same size welded together to form an inner water chamber and an outer air chamber; (ii) three layers of; for example, thermoplastic polyurethane (“TPU”) or vinyl, material welded together to form an inner water chamber and an outer air chamber, but wherein the material for the outer chamber is larger so that the resulting chamber strikes a larger, better fitting circumference when wrapped around the user's limb; and (iii) two layers of, for example, thermoplastic polyurethane (“TPU”) or vinyl, material welded together to form a single water chamber for thermal and compression therapies. With alternative (iii), water is pressurized and air is not used.
Alternatives (i) and (ii) employ a cold water inner wrap with a compression air bladder integrated t to the outside of it. The resulting wrap 200 is likely made from three layers of material bonded together via any technique described above. The inner chamber receives water for cooling, while the outer chamber receives pressurized air for compression. The inner and outer chambers are substantially separate in one embodiment but are joined together continuously or intermittently at the closure edges so that closing wrap 200 involves one step rather than two. In one embodiment, unlike the DVT cuff 100, the outer chamber for wrap 200 will be a single pressurized air chamber and will not have separate sub-chambers.
The water delivered to wrap 200 is via a water pump. A suitable system for providing water to wrap 200 is disclosed in commonly owned (i) U.S. patent application Ser. No. 12/973,476, entitled, “Cold Therapy Apparatus Using Heat Exchanger”, filed Dec. 20, 2010, and (ii) U.S. patent application Ser. No. 13/418,857, entitled, “Cold Therapy Systems And Methods”, filed Mar. 13, 2012, the entire contents of each of which are incorporated herein by reference and relied upon.
Regarding wrap alternative (i), the outer surface of the outer air compression layer is in one embodiment resistant to stretching so as to be able to provide efficient compression. This can cause wrinkling and bunching of the inner water cooling layer when the length of both layers is the same in (i). As a remedy, it is contemplated in
Alignment tabs 212 align the three sheets 206, 208 and 210 during the sealing process. The alignment tabs 212 cause the extra material of larger sheets 206 and 208 to bunch in the middle of periphery P. This extra, bunched material is then available to expand when chambers 202 and 204 are subject to water and air inflation, respectively, so that outer sheets 206 and 208 place less stress on their neighboring inner sheet due to the expanded radii of the outer sheets 206 and 208. The additional material allows wrap 200 when inflated to be under less overall stress, lessening the likelihood that inner sheets 204 and 206 will bunch or crinkle.
Aspects of the subject matter described herein may be useful alone or in combination one or more other aspect described herein. Without limiting the foregoing description, in a first aspect of the present disclosure, a pressure therapy system includes: an air pump; a pneumatic line pressurized by the air pump; and a cuff in fluid communication with the pneumatic line, the cuff including flaps sized and shaped to extend around a user's limb, a first chamber and a second chamber separated fluidly by the cuff from the first chamber, wherein the pneumatic line splits into first and second line segments or openings, the first line segment or opening communicating fluidly with the first separated chamber, the second line segment or opening communicating fluidly with the second separated chamber, and wherein the second line segment or opening or a pathway of the cuff leading to the second separated chamber includes a flow restricting structure that delays pressurized air from reaching the second chamber relative to the first chamber.
In accordance with a second aspect of the present disclosure, which may be used in combination with any other aspect listed herein, the cuff is structured so that the first chamber is located distal from the second chamber relative to the user's heart when worn around the user's limb.
In accordance with a third aspect of the present disclosure, which may be used in combination with any other aspect listed herein, the cuff is removably attachable around the user's limb.
In accordance with a fourth aspect of the present disclosure, which may be used in combination with any other aspect listed herein, the first and second separated chambers are located on the cuff inside of the flaps.
In accordance with a fifth aspect of the present disclosure, which may be used in combination with any other aspect listed herein, the flow restricting structure includes a narrowed passageway located in the second line segment or opening.
In accordance with a sixth aspect of the present disclosure, which may be used in combination with any other aspect listed herein including the fifth aspect, the narrowed passageway is located in a connector connecting the pneumatic line with the first and second line segments or openings.
In accordance with a seventh aspect of the present disclosure, which may be used in combination with any other aspect listed herein, the flow restricting structure includes a tortuous air flow restriction in the pathway of the cuff leading to the second separated chamber.
In accordance with an eighth aspect of the present disclosure, which may be used in combination with any other aspect listed herein including the seventh aspect, the tortuous air flow restriction includes alternating baffles in the pathway.
In accordance with a ninth aspect of the present disclosure, which may be used in combination with any other aspect listed herein including the seventh aspect, the first and second separated chambers and the tortuous air flow restrictions are sealed via heat sealing, sonic sealing or solvent bond.
In accordance with a tenth aspect of the present disclosure, which may be used in combination with any other aspect listed herein including the seventh aspect, the flow restricting structure includes (i) the tortuous air flow restriction in the pathway and (ii) a narrowed passageway located in the second line segment or opening.
In accordance with an eleventh aspect of the present disclosure, which may be used in combination with any other aspect listed herein, the flow restricting structure includes a check valve located in the second line segment or opening.
In accordance with a twelfth aspect of the present disclosure, which may be used in combination with other aspect listed herein including the eleventh aspect, the check valve is located in a connector connecting the pneumatic line with the first and second line segments or openings.
In accordance with a thirteenth aspect of the present disclosure, which may be used in combination with other aspect listed herein including the eleventh aspect, the flow restricting structure includes (i) the check valve located in the second line segment or opening and (ii) a tortuous air flow restriction in the pathway of the cuff leading to the second separated chamber.
In accordance with a fourteenth aspect of the present disclosure, which may be used in combination with any other aspect listed herein, the system includes a reservoir, the air pump pressurizing the pneumatic line via the reservoir.
In accordance with a fifteenth aspect of the present disclosure, which may be used with any other aspect listed herein, the pneumatic line splits outside the cuff.
In accordance with a sixteenth aspect of the present disclosure, which may be used with any other aspect listed herein, the pneumatic line splits inside the cuff.
In accordance with a seventeenth aspect of the present disclosure, which may be used with any other aspect listed herein, a pressure therapy system includes: electronics; an air pump controlled by the electronics; first and second control valves controlled by the electronics; first and second bleed valves controlled by the electronics; a first pneumatic line in fluid communication with the first control valve and the first bleed valve; a second pneumatic line in fluid communication with the second control valve and the second bleed valve; a first cuff in fluid communication with the first pneumatic line, the first cuff including flaps sized and shaped to extend around a user's limb, a distal chamber and a proximal chamber, and wherein the first cuff or the first pneumatic line includes a first flow restricting structure that delays pressurized air from reaching the proximal chamber relative to the distal chamber; a second cuff in fluid communication with the second pneumatic line, the second cuff including flaps sized and shaped to extend around a user's limb, a distal chamber and a proximal chamber, and wherein the second cuff or the second pneumatic line includes a second flow restricting structure that delays pressurized air from reaching the proximal chamber relative to the distal chamber; and wherein the electronics is configured to open and close the first and second control valves and the first and second bleed valves so that pressurization of the first and second cuffs is staggered, lessening an amount of pressurization needed.
In accordance with an eighteenth aspect of the present disclosure, which may be used with any other aspect listed herein including the seventeenth aspect, the system includes a third pneumatic line leading to a pneumatic chamber of a wrap, the wrap further including a liquid chamber.
In accordance with a nineteenth aspect of the present disclosure, which may be used with any other aspect listed herein including the eighteenth aspect, the system includes a liquid pump in fluid communication with the liquid chamber.
In accordance with a twentieth aspect of the present disclosure, which may be used with any other aspect listed herein including the eighteenth aspect, the electronics is configured to cause the pressure in the pneumatic chamber of the wrap to be ramped up and down linearly.
In accordance with a twenty-first aspect of the present disclosure, which may be used with any other aspect listed herein including the eighteenth aspect, the system includes a third control valve and a third bleed valve in fluid communication with the third pneumatic lines, and wherein the electronics is configured to open and close the first, second and third control valves and the first, second and third bleed valves so that pressurization of the first cuff, second cuff and wrap and staggered, lessening the amount of pressurization needed.
In accordance with a twenty-second aspect of the present disclosure, which may be used with any other aspect listed herein, a pressure therapy system includes: an air pump; a pneumatic line pressurized by the air pump; and a cuff in fluid communication with the pneumatic line, the cuff including flaps sized and shaped to extend around a user's limb, a first chamber and a second chamber, an inlet check valve and an outlet check valve communicating fluidly with the second air chamber, the inlet check valve delaying pressurized air from reaching the second chamber relative to the first chamber when pressure is applied to the pneumatic line, the outlet check valve enabling pressure in the second chamber to dissipate when the pneumatic line is depressurized.
In accordance with a twenty-third aspect of the present disclosure, which may be used with any other aspect listed herein including the twenty-second aspect, the inlet and outlet check valves are provided in a connector that communicate fluidly with the first and second chambers.
In accordance with a twenty-fourth aspect of the present disclosure, which may be used with any other aspect listed herein, the second chamber is separated fluidly by the cuff from the first chamber, wherein the pneumatic line splits into first and second line segments or openings, the first line segment or opening communicating fluidly with the first separated chamber, the second line segment or opening communicating fluidly with the second separated chamber, and wherein the second line segment or opening or a pathway of the cuff leading to the second separated chamber includes the inlet and outlet check valves.
In accordance with a twenty-fifth aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present subject matter and without diminishing its intended advantages. It is therefore intended that such changes and modifications be covered by the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
222690 | Goldschmidt | Dec 1879 | A |
1896953 | Hassell | May 1931 | A |
2260134 | Ballman | Oct 1939 | A |
2726658 | Chesseu | Dec 1955 | A |
3316732 | Burton | May 1967 | A |
3587577 | Solyanka | Jun 1971 | A |
3625279 | Mayo | Dec 1971 | A |
3648765 | Starr | Mar 1972 | A |
3744555 | Fletcher et al. | Jul 1973 | A |
3811431 | Apstein | May 1974 | A |
3892229 | Taylor et al. | Jul 1975 | A |
3901221 | Nicholson et al. | Aug 1975 | A |
3918458 | Nethery | Nov 1975 | A |
3942518 | Tenteris et al. | Mar 1976 | A |
3971398 | Taylor et al. | Jul 1976 | A |
3993053 | Grossan | Nov 1976 | A |
4013069 | Hasty | Mar 1977 | A |
4030488 | Hasty | Jun 1977 | A |
4149529 | Copeland et al. | Apr 1979 | A |
4156425 | Arkans | May 1979 | A |
4186732 | Christoffel | Feb 1980 | A |
4198961 | Arkans | Apr 1980 | A |
4202325 | Villari et al. | May 1980 | A |
4206751 | Schneider | Jun 1980 | A |
4207875 | Arkans | Jun 1980 | A |
4253449 | Arkans et al. | Mar 1981 | A |
4306747 | Moss | Dec 1981 | A |
4311135 | Brueckner et al. | Jan 1982 | A |
4370975 | Wright | Feb 1983 | A |
4375217 | Arkans | Mar 1983 | A |
4396010 | Arkans | Aug 1983 | A |
4453538 | Whitney | Jun 1984 | A |
4501126 | Norton | Feb 1985 | A |
4694521 | Tominaga | Sep 1987 | A |
4773494 | Anderson | Sep 1988 | A |
4821354 | Little | Apr 1989 | A |
4841956 | Gardner et al. | Jun 1989 | A |
4844072 | French et al. | Jul 1989 | A |
4966145 | Kikumoto et al. | Oct 1990 | A |
5022387 | Hasty | Jun 1991 | A |
5109832 | Proctor et al. | May 1992 | A |
5186163 | Dye | Feb 1993 | A |
5218954 | van Bemmelen | Jun 1993 | A |
5241951 | Mason et al. | Sep 1993 | A |
5241958 | Noeldner | Sep 1993 | A |
5261482 | Lomax et al. | Nov 1993 | A |
5263473 | McWhorter | Nov 1993 | A |
5330519 | Mason et al. | Jul 1994 | A |
5370603 | Newman | Dec 1994 | A |
5383894 | Dye | Jan 1995 | A |
5496262 | Johnson, Jr. et al. | Mar 1996 | A |
5588955 | Johnson et al. | Dec 1996 | A |
5626556 | Tobler et al. | May 1997 | A |
5647051 | Neer | Jul 1997 | A |
5669872 | Fox | Sep 1997 | A |
5730136 | Laufer et al. | Mar 1998 | A |
5843007 | McEwen et al. | Dec 1998 | A |
5865841 | Kolen et al. | Feb 1999 | A |
5951502 | Peeler et al. | Sep 1999 | A |
5968073 | Jacobs | Oct 1999 | A |
5980561 | Kolen et al. | Nov 1999 | A |
5989285 | DeVilbiss et al. | Nov 1999 | A |
6007559 | Arkans | Dec 1999 | A |
6080120 | Sandman et al. | Jun 2000 | A |
6129688 | Arkans | Oct 2000 | A |
6290662 | Morris et al. | Sep 2001 | B1 |
6296617 | Peeler et al. | Oct 2001 | B1 |
6358219 | Arkans | Mar 2002 | B1 |
6387065 | Tumey | May 2002 | B1 |
6436064 | Kloecker | Aug 2002 | B1 |
6440093 | McEwen et al. | Aug 2002 | B1 |
6447467 | Barak | Sep 2002 | B1 |
6463612 | Potter | Oct 2002 | B1 |
6463934 | Johnson, Jr. et al. | Oct 2002 | B1 |
6478757 | Barak | Nov 2002 | B1 |
6494852 | Barak et al. | Dec 2002 | B1 |
6544202 | McEwen et al. | Apr 2003 | B2 |
6589194 | Calderon et al. | Jul 2003 | B1 |
6592534 | Rutt et al. | Jul 2003 | B1 |
6685661 | Peled | Feb 2004 | B2 |
7044924 | Roth et al. | May 2006 | B1 |
7063676 | Barak et al. | Jun 2006 | B2 |
7191798 | Edelman et al. | Mar 2007 | B2 |
7207959 | Chandran | Apr 2007 | B1 |
7211104 | Edelman | May 2007 | B2 |
7282038 | Gillis et al. | Oct 2007 | B2 |
7354410 | Perry et al. | Apr 2008 | B2 |
7354411 | Perry et al. | Apr 2008 | B2 |
7637879 | Barak et al. | Dec 2009 | B2 |
7641623 | Biondo et al. | Jan 2010 | B2 |
7658205 | Edelman et al. | Feb 2010 | B1 |
7694693 | Edelman et al. | Apr 2010 | B1 |
7708707 | Cook et al. | May 2010 | B2 |
7819829 | Chandran | Oct 2010 | B1 |
7862525 | Carkner et al. | Jan 2011 | B2 |
7871387 | Tordella et al. | Jan 2011 | B2 |
7896823 | Mangrum et al. | Mar 2011 | B2 |
7909783 | Mayer et al. | Mar 2011 | B2 |
7909861 | Balachandran et al. | Mar 2011 | B2 |
7931606 | Meyer | Apr 2011 | B2 |
7942838 | Farrow | May 2011 | B2 |
7959588 | Wolpa | Jun 2011 | B1 |
7967766 | Ravikumar | Jun 2011 | B2 |
8394042 | Mirza | Mar 2013 | B1 |
20020115949 | Kuslich et al. | Aug 2002 | A1 |
20040054306 | Roth et al. | Mar 2004 | A1 |
20050070828 | Hampson et al. | Mar 2005 | A1 |
20050187500 | Perry et al. | Aug 2005 | A1 |
20060161081 | Barak et al. | Jul 2006 | A1 |
20080058911 | Parish et al. | Mar 2008 | A1 |
20080077063 | Meyer et al. | Mar 2008 | A1 |
20090069731 | Parish et al. | Mar 2009 | A1 |
20090124944 | Ravikumar | May 2009 | A1 |
20090293887 | Wilkes et al. | Dec 2009 | A1 |
20090299239 | Meyer et al. | Dec 2009 | A1 |
20090299249 | Wilkes et al. | Dec 2009 | A1 |
20090299255 | Kazala et al. | Dec 2009 | A1 |
20090299256 | Barta | Dec 2009 | A1 |
20090299257 | Long et al. | Dec 2009 | A1 |
20090299307 | Barta et al. | Dec 2009 | A1 |
20090299308 | Kazala et al. | Dec 2009 | A1 |
20090299340 | Kazala et al. | Dec 2009 | A1 |
20090299341 | Kazala et al. | Dec 2009 | A1 |
20090299342 | Cavanaugh et al. | Dec 2009 | A1 |
20100030306 | Edelman et al. | Feb 2010 | A1 |
20100081977 | Vess | Apr 2010 | A1 |
20100100017 | Maguina | Apr 2010 | A1 |
20100106029 | Fraden | Apr 2010 | A1 |
20100137764 | Eddy | Jun 2010 | A1 |
20100210982 | Balachandran et al. | Aug 2010 | A1 |
20100249679 | Perry et al. | Sep 2010 | A1 |
20110015587 | Tumey et al. | Jan 2011 | A1 |
20110015589 | Svedman et al. | Jan 2011 | A1 |
20110015590 | Svedman et al. | Jan 2011 | A1 |
20110015593 | Svedman et al. | Jan 2011 | A1 |
20110071447 | Liu et al. | Mar 2011 | A1 |
20110077723 | Parish et al. | Mar 2011 | A1 |
20110082401 | Iker et al. | Apr 2011 | A1 |
20110087142 | Ravikumar et al. | Apr 2011 | A1 |
20110092927 | Wilkes et al. | Apr 2011 | A1 |
20110093050 | Damkoehler | Apr 2011 | A1 |
20110152796 | Kazala, Jr. et al. | Jun 2011 | A1 |
20110166480 | Mayer et al. | Jul 2011 | A1 |
20110178481 | Locke et al. | Jul 2011 | A1 |
20110190675 | Vess | Aug 2011 | A1 |
20110196269 | Arkans | Aug 2011 | A1 |
20110245743 | Eddy | Oct 2011 | A1 |
20110257573 | Hong et al. | Oct 2011 | A1 |
20110275983 | Quisenberry et al. | Nov 2011 | A1 |
Number | Date | Country |
---|---|---|
2601496 | Mar 2008 | CA |
1990039 | Nov 2008 | EP |
2275165 | Jan 2011 | EP |
S950163 | Dec 1995 | IE |
WO2009158131 | Dec 2009 | WO |
WO2011090986 | Jul 2011 | WO |
Entry |
---|
Orthofix International, “Orthofix International Introduces Fusion Lateral OA Brace With New Low-Profile Hinge,” News Blaze, published Dec. 4, 2009, http://newsblaze.com/story/2009120405052100002.bw/topstory.html. |
Breg Incorporated, “Fusion OA,” published 2009, http://www.breg.com/knee-bracing/oa/fusion-oa.html. |
Bledsoe Brace Systems, “Bledsoe Cold Control,” published 2008, http://bledsoebrace.com/products/ cold—control.asp. |
International Preliminary Report on Patentability issued Oct. 25, 2013 for related Intl. Appin. No. PCT/US2012/029068. |
Number | Date | Country | |
---|---|---|---|
20130245519 A1 | Sep 2013 | US |